Id2 mediates oligodendrocyte precursor cell maturation arrest and is tumorigenic in a PDGF-rich microenvironment
Matthew C Havrda1, Brenton R Paolella, Cong Ran
1Authors' Affiliations: Norris Cotton Cancer Center; Departments of Genetics; Pediatrics; and Pharmacology and Toxicology, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire.
Abstract:
Maturation defects occurring in adult tissue progenitor cells have the potential to contribute to tumor development; however, there is little experimental evidence implicating this cellular mechanism in the pathogenesis of solid tumors. Inhibitor of DNA-binding 2 (Id2) is a transcription factor known to regulate the proliferation and differentiation of primitive stem and progenitor cells. Id2 is derepressed in adult tissue neural stem cells (NSC) lacking the tumor suppressor Tp53 and modulates their proliferation. Constitutive expression of Id2 in differentiating NSCs resulted in maturation-resistant oligodendroglial precursor cells (OPC), a cell population implicated in the initiation of glioma. Mechanistically, Id2 overexpression was associated with inhibition of the Notch effector Hey1, a bHLH transcription factor that we here characterize as a direct transcriptional repressor of the oligodendroglial lineage determinant Olig2. Orthotopic inoculation of NSCs with enhanced Id2 expression into brains of mice engineered to express platelet-derived growth factor in the central nervous system resulted in glioma. These data implicate a mechanism of altered NSC differentiation in glioma development and characterize a novel mouse model that reflects key characteristics of the recently described proneural subtype of glioblastoma multiforme. Such findings support the emerging concept that the cellular and molecular characteristics of tumor cells are linked to the transformation of distinct subsets of adult tissue progenitors.
Insights
Altered neural stem cell (NSC) differentiation due to Inhibitor of DNA-binding 2 (Id2) promotes glioma development. This study identifies a novel mechanism and mouse model for studying this brain tumor subtype.
Area of Science:
- Neuroscience
- Cancer Biology
- Developmental Biology
Background:
- Maturation defects in adult tissue progenitor cells can lead to tumor development, but evidence in solid tumors is limited.
- Inhibitor of DNA-binding 2 (Id2) regulates stem and progenitor cell proliferation and differentiation.
- Id2 is upregulated in neural stem cells (NSCs) lacking the tumor suppressor Tp53, influencing their proliferation.
Purpose of the Study:
- To investigate the role of Id2 in NSC differentiation and its potential contribution to glioma pathogenesis.
- To characterize a novel mouse model for studying glioma development.
Main Methods:
- Examined Id2 expression in neural stem cells (NSCs) and its effect on differentiation.
- Investigated the molecular mechanisms involving Id2, Hey1, and Olig2.
- Generated a mouse model by orthotopically inoculating NSCs with enhanced Id2 expression.
Main Results:
- Constitutive Id2 expression in NSCs led to maturation-resistant oligodendroglial precursor cells (OPCs), linked to glioma initiation.
- Id2 overexpression inhibited Hey1, a repressor of the oligodendroglial lineage determinant Olig2.
- Orthotopic inoculation of Id2-enhanced NSCs in mice resulted in glioma formation.
Conclusions:
- Altered NSC differentiation, driven by Id2, is implicated in glioma development.
- A novel mouse model mimicking proneural glioblastoma multiforme has been characterized.
- Tumor cell characteristics are linked to the transformation of specific adult tissue progenitors.
More Related Videos
Related Concept Videos
Abnormal Proliferation
TGF - β Signaling Pathway
EPS and iPS Cells in Disease Research
iPS Cell Differentiation


